Gordon Kwanlyp Lee, MD
Plastic and Reconstructive Surgery · Orange
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
- Since medical school
- 29 years
- Stanford University School of Medicine, 1997
Offices
1 location · Regents of the University of California · 14 clinicians in this group
Looking this up.
Hospitals listed: Uci Health-Orange. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office at (714) 456-7004 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A68322 · Current
Licensed to practise in California · since 1999 · expires 2027-05-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Plastic Surgery - Plastic Surgery
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Uci Health-OrangeOrange, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of Chao Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.44 (3.82 to 7.06) · 2,934 cases, Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 82.98 (46.2 to 119.76) · 170 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.422, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.56, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.547, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.356, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.449, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.6 to 1) · 1,287 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Uci Health-Orange
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 2 better, 7 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.44 (3.82 to 7.06) · 2,934 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 82.98 (46.2 to 119.76) · 170 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.422 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.56 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.547 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.356 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.449 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 1,287 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.25 to 1.87) · 2,297 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.67 to 1.13) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 59 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 104 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.3 · 331 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 416 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 330 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,269 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.33) · 8,263 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.01 to 0.37) · 8,703 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.95 (0.57 to 3.32) · 1,647 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.52 (1.33 to 3.71) · 2,756 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.15 (2.82 to 11.48) · 1,643 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.78 (2.24 to 7.33) · 1,680 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.98 (0.61 to 3.36) · 871 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.28 (0 to 0.77) · 7,232 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 170 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0.546 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 165 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 556 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 75.5 · 113 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0 · 391 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.4 · 436 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 556 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.1 to 6.6) · 846 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.8 (10 to 14) · 846 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.9 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21 · 110 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.8 (8.6 to 13.8) · 2,457 cases | No different | Jan 2022 – Dec 2024 |
What patients said (575 patients answered, 16% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 65% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$30,969
Medicare paid this office $30,969 for 39 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (30+ min) | 21 | $1,669 | $79 |
| New patient visit (45+ min) | 11 | $1,381 | $126 |
Procedures Medicare counted
| Mastectomy | 39 | More than 91% of doctors who do this |
| Removal of tissue | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Graft using patient's fat removed by liposuction and inserted into trunk, breasts, scalp, arms, or legs, each additional 50.0 cc | – | – | – | – | 87 | – |
| Placement of mesh to repair incisional or abdominal hernia | – | 12 | 12 | – | – | – |
| Graft using patient's fat removed by liposuction and inserted into trunk, breasts, scalp, arms, or legs, 50.0 cc or less | – | – | – | – | 13 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
39 Original Medicare patients in 2024. Average age 70 · Health risk score 1.02. At or below the middle of the specialty; the typical plastic and reconstructive surgery clinician is at 1.21.
Conditions among them: Cancer 75% · High blood pressure 51%.
The office billed $330,928, Medicare allowed $38,927 and paid $30,969; for 98 services of 33 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 39 | 98 | 70 | 1.02 | $330,928 | $30,969 |
| 2023 | 78 | 307 | 67 | 1.89 | $1,023,803 | $109,330 |
| 2022 | 111 | 280 | 67 | 1.86 | $796,297 | $101,235 |
| 2021 | 105 | 297 | 68 | 1.46 | $758,772 | $87,636 |
| 2020 | 81 | 237 | 68 | 1.84 | $609,478 | $85,949 |
| 2019 | 58 | 132 | 64 | 1.47 | $476,057 | $52,805 |
| 2018 | 89 | 215 | 67 | 1.66 | $642,762 | $89,073 |
| 2017 | 104 | 246 | 67 | 1.43 | $816,281 | $105,687 |
| 2016 | 112 | 251 | 70 | 1.70 | $751,199 | $96,338 |
| 2015 | 99 | 243 | 65 | 1.24 | $772,047 | $96,087 |
| 2014 | 134 | 292 | 66 | 1.48 | $843,198 | $113,758 |
| 2013 | 102 | 286 | 66 | 1.42 | $797,805 | $110,819 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Graft using patient's fat removed by liposuction and inserted into trunk, breasts, scalp, arms, or legs, each additional 50.0 cc | 13 | $11,793 | $136 |
| Graft using patient's fat removed by liposuction and inserted into trunk, breasts, scalp, arms, or legs, 50.0 cc or less | 13 | $3,686 | $284 |
| Short return visit (20+ min) | 30 | $2,047 | $55 |
| New patient visit (30+ min) | 23 | $1,515 | $66 |
| Short return visit | 14 | $490 | $31 |
2022: 3 services
| New patient visit (30+ min) | 53 | $3,477 | $66 |
| Short return visit (20+ min) | 32 | $2,417 | $56 |
| Short return visit | 15 | $546 | $30 |
2021: 4 services
| New patient visit (30+ min) | 52 | $3,713 | $71 |
| Placement of mesh to repair incisional or abdominal hernia | 12 | $2,824 | $235 |
| Short return visit (20+ min) | 23 | $1,658 | $53 |
| Short return visit | 25 | $1,006 | $27 |
2020: 4 services
| Placement of mesh to repair incisional or abdominal hernia | 12 | $2,868 | $239 |
| New patient visit (30+ min) | 36 | $2,362 | $66 |
| Short return visit (20+ min) | 24 | $1,129 | $40 |
| Short return visit | 11 | $454 | $24 |
2019: 2 services
| New patient visit (30+ min) | 23 | $1,508 | $66 |
| Short return visit (20+ min) | 19 | $1,068 | $44 |
2018: 4 services
| Repair of incisional or abdominal hernia | 12 | $6,520 | $543 |
| Placement of mesh to repair incisional or abdominal hernia | 17 | $3,716 | $219 |
| New patient visit (30+ min) | 32 | $2,039 | $64 |
| Short return visit (20+ min) | 30 | $1,367 | $44 |
2017: 3 services
| Placement of mesh to repair incisional or abdominal hernia | 14 | $3,198 | $228 |
| New patient visit (30+ min) | 44 | $2,823 | $64 |
| Short return visit (20+ min) | 26 | $1,278 | $40 |
2016: 5 services
| Reconstruction of breast using tissue expander | 12 | $21,209 | $1,767 |
| New patient visit (30+ min) | 58 | $3,724 | $64 |
| Placement of mesh to repair incisional or abdominal hernia | 11 | $2,514 | $229 |
| Short return visit (20+ min) | 31 | $1,504 | $44 |
| Short return visit | 13 | $379 | $22 |
2015: 3 services
| New patient visit (30+ min) | 25 | $1,563 | $63 |
| Short return visit (20+ min) | 14 | $592 | $42 |
| Short return visit | 28 | $497 | $18 |
2014: 6 services
| Repair of incisional or abdominal hernia | 11 | $5,801 | $527 |
| New patient visit (45+ min) | 37 | $4,122 | $111 |
| Placement of mesh to repair incisional or abdominal hernia | 14 | $3,188 | $228 |
| New patient visit (30+ min) | 28 | $1,755 | $63 |
| Short return visit (20+ min) | 24 | $1,092 | $44 |
| Short return visit | 13 | $357 | $22 |
2013: 6 services
| Creation of muscle graft to trunk | 14 | $20,121 | $1,006 |
| Placement of mesh to repair incisional or abdominal hernia | 14 | $3,138 | $224 |
| New patient visit (45+ min) | 23 | $2,575 | $112 |
| New patient visit (30+ min) | 24 | $1,587 | $66 |
| Short return visit (20+ min) | 12 | $528 | $44 |
| Short return visit | 13 | $274 | $20 |
Drugs they prescribed that Part D paid
$99
Pharmacies billed $99 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
13 generic and 0 brand-name prescriptions · $99 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 13 | None | None | 0% | $99 |
| 2023 | 15 | None | None | None | $511 |
| 2022 | 16 | 15 | None | None | $145 |
| 2021 | 33 | 13 | None | None | $475 |
| 2020 | 51 | 21 | None | None | $759 |
| 2019 | 30 | 12 | 0% (0) | None | $396 |
| 2018 | 63 | 29 | None | None | $1,070 |
| 2017 | 87 | 34 | None | None | $2,562 |
| 2016 | 28 | 22 | None | None | $784 |
| 2015 | 40 | 19 | None | None | $2,701 |
| 2014 | 119 | 47 | 18% (21) | None | $9,166 |
| 2013 | 155 | 43 | 16% (25) | None | $11,478 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 1 drug
| Omeprazole | 11 | $52 | $5 |
2020: 1 drug
| Omeprazole | 12 | $39 | $3 |
2019: 1 drug
| Omeprazole | 12 | $35 | $3 |
2018: 2 drugs
| Polyethylene Glycol 3350 | 13 | $571 | $44 |
| Omeprazole | 11 | $37 | $3 |
2017: 2 drugs
| Cephalexin | 22 | $136 | $6 |
| Omeprazole | 11 | $44 | $4 |
2014: 2 drugs
| Hydrocodone-Acetaminophen | 21 | $208 | $10 |
| Cephalexin | 14 | $117 | $8 |
2013: 2 drugs
| Hydrocodone-Acetaminophen | 20 | $210 | $10 |
| Cephalexin | 12 | $91 | $8 |
Money from drug and device companies
$4,006 in 2025
| 2025 | 12 | 34 | $1,750 | $4,006 |
| 2024 | 14 | 62 | $1,000 | $5,826 |
| 2023 | 5 | 16 | $2,800 | $8,869 |
| 2022 | 5 | 19 | $6,500 | $8,431 |
| 2021 | 7 | 10 | $3,900 | $4,377 |
| 2020 | 4 | 6 | $3,250 | $3,787 |
| 2019 | 6 | 26 | $11,250 | $13,693 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| MIMEDX Group | None | $1,750 | 2 payments
|
| TELA Bio | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $483 | 9 payments
|
| Mentor Worldwide | Mentor Memorygel Resterilizable Gel Sizer | $428 | 6 payments
|
| Motiva USA | Motiva Implant Matrix | $388 | 3 payments
|
| Rti Surgical | Cortiva Allograft Dermis | $326 | 2 payments
|
| Abbvie | Natrelle Saline-Filled Breast Implants | $192 | 3 payments
|
See all 34 published payments
| Becton Dickinson and | Meals · 2025-12-11 | Surgiphor | $33 |
| TELA Bio | Meals · 2025-12-11 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $56 |
| Ethicon US | Meals · 2025-12-10 | Ethicon | $8 |
| Medical Device Business Services | Meals · 2025-12-10 | Ethicon | $123 |
| TELA Bio | Meals · 2025-12-09 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $44 |
| TELA Bio | Meals · 2025-10-27 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $43 |
| Motiva USA | Meals · 2025-10-24 | Motiva Implant Matrix | $150 |
| Rti Surgical | Meals · 2025-10-11 | Cortiva Allograft Dermis | $177 |
| W. L. Gore & Associates | Meals · 2025-10-02 | Gore Bio-A Tissue Reinforcement | $59 |
| Ethicon US | Meals · 2025-10-01 | Monocryl | $22 |
| MIMEDX Group | Paid to speak or teach · 2025-09-18 | None | $500 |
| Mentor Worldwide | Meals · 2025-09-10 | Mentor Memorygel Resterilizable Gel Sizer | $49 |
| Mentor Worldwide | Meals · 2025-08-30 | Mentor Memorygel Resterilizable Gel Sizer | $66 |
| TELA Bio | Meals · 2025-08-06 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $54 |
| Ethicon US | Meals · 2025-07-31 | Monocryl | $100 |
| Musculoskeletal Transplant Foundation | Meals · 2025-07-09 | None | $26 |
| Abbvie | Meals · 2025-06-04 | Artia | $24 |
| MIMEDX Group | Paid to speak or teach · 2025-06-02 | None | $1,250 |
| Motiva USA | Meals · 2025-05-28 | Motiva Implant Matrix | $96 |
| TELA Bio | Meals · 2025-05-28 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $44 |
| Access Pro Medical | Meals · 2025-05-21 | Matriderm | $36 |
| Mentor Worldwide | Meals · 2025-05-17 | Mentor Memorygel Resterilizable Gel Sizer | $113 |
| Rti Surgical | Meals · 2025-05-07 | Cortiva Allograft Dermis | $150 |
| Motiva USA | Meals · 2025-04-30 | Motiva Implant Matrix | $142 |
| Abbvie | Meals · 2025-04-09 | Artia | $49 |
| TELA Bio | Meals · 2025-03-24 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $37 |
| TELA Bio | Meals · 2025-03-19 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $28 |
| Mentor Worldwide | Meals · 2025-03-08 | Mentor Memorygel Resterilizable Gel Sizer | $42 |
| TELA Bio | Meals · 2025-02-28 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $61 |
| Abbvie | Meals · 2025-02-26 | Natrelle Saline-Filled Breast Implants | $119 |
| Ethicon US | Meals · 2025-02-11 | Stratafix | $33 |
| Mentor Worldwide | Meals · 2025-02-03 | Mentor Memorygel Resterilizable Gel Sizer | $128 |
| Mentor Worldwide | Meals · 2025-01-13 | Mentor Memorygel Resterilizable Gel Sizer | $29 |
| TELA Bio | Meals · 2025-01-02 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $117 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $5,826
| TELA Bio | Ovitex 2s | $2,571 | 19 payments
|
| Abbvie | Natrelle Saline-Filled Breast Implants | $1,909 | 17 payments
|
| Mentor Worldwide | Mentor Memorygel Resterilizable Gel Sizer | $370 | 12 payments
|
| Ethicon US | Stratafix | $184 | 3 payments
|
| Acera Surgical | Restrata Wound Matrix | $148 | 1 payment
|
| Kerecis | Kerecis Omega3 Surgiclose | $145 | 1 payment
|
| W. L. Gore & Associates | Gore Enform Preperitoneal Biomaterial | $137 | 2 payments
|
| Organogenesis | Puraply Wound Matrix | $122 | 1 payment
|
| Aroa Biosurgery | None | $74 | 1 payment
|
| Avita Medical Americas | Recell | $49 | 1 payment
|
| MIMEDX Group | None | $40 | 1 payment
|
| Axogen | Avance Nerve Graft | $38 | 1 payment
|
| Vioptix | T. Ox Tissue Oximeter | $25 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $15 | 1 payment
|
2023: $8,869
| Integra LifeSciences | Integra | $6,883 | 4 payments
|
| TELA Bio | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $1,327 | 4 payments
|
| Abbvie | Natrelle Saline-Filled Breast Implants | $422 | 5 payments
|
| Musculoskeletal Transplant Foundation | None | $191 | 1 payment
|
| Baxter Healthcare | None | $46 | 2 payments
|
2022: $8,431
| W. L. Gore & Associates | Gore Synecor Biomaterial | $6,500 | 3 payments
|
| Integra LifeSciences | Advanced Wound Care | $1,536 | 10 payments
|
| Allergan | Natrelle Saline-Filled Breast Implants | $155 | 4 payments
|
| Musculoskeletal Transplant Foundation | None | $147 | 1 payment
|
| Stryker | 1688 | $92 | 1 payment
|
2021: $4,377
| W. L. Gore & Associates | Gore Synecor Biomaterial | $3,900 | 1 payment
|
| Davol | Phasix | $243 | 3 payments
|
| Integra LifeSciences | Surgimend | $151 | 2 payments
|
| Stryker | Spy-Phi System | $41 | 1 payment
|
| Allergan | Natrelle Saline-Filled Breast Implants | $16 | 1 payment
|
| DePuy Synthes Sales | Na | $14 | 1 payment
|
| Osteomed | Neuro-Osteomatch | $13 | 1 payment
|
2020: $3,787
| Integra LifeSciences | Flowable | $3,250 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $361 | 3 payments
|
| Axogen | Avance Nerve Graft | $91 | 1 payment
|
| Stryker | Spy Technology | $84 | 1 payment
|
2019: $13,693
| TEI Biosciences | Surgimend | $8,184 | 10 payments
|
| Integra LifeSciences | Bilayer Wound Matrix (Bwm) | $3,962 | 6 payments
|
| Medical Device Business Services | Artoura Breast Tissue Expander | $979 | 6 payments
|
| Musculoskeletal Transplant Foundation | None | $518 | 2 payments
|
| Mentor Worldwide | Spectrum Adjustable Saline Breast Implant | $28 | 1 payment
|
| Baxter Healthcare | No Related Product | $21 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1326009572
- Licence
- CA A68322California A68322: Current · expires 2027-05-31
- Trained
- Stanford University School of Medicine, 1997 · 29 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- TX 1591752-03
- Taxonomy
- Federal specialty code 208200000X (208200000X); Plastic and reconstructive surgery (2086S0122X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2006-03-29
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 770 Welch Rd, Palo Alto, CA, 94304